• Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate. l'Ami et al., Clin Exp Rheumatol. 2017 May-Jun;35(3):431-437:

 

  • Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity. Plasencia et al., Clin Exp Rheumatol. 2016 Jul-Aug;34(4):655-62. Epub 2016 May 19. 

 

  • Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up. Kneepkens et al., Ann Rheum Dis 2014 May 7.